Back
NovoCure Vs. Summit Midstream Partners LP Industry Stock Comparison
Sell
41
NVCR
NovoCure
Last Price:
21.35
Seasonality Move:
5.48%
Sell
38
SMLP
Summit Midstream Partners LP
Last Price:
32.57
Seasonality Move:
-10.49%
Sell
41
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $21.34. The Score for NVCR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Summit Midstream Partners LP (SMLP)
is a Sell
Is Summit Midstream Partners LP a Buy, Sell or Hold?
- The current Summit Midstream Partners LP [SMLP] share price is $32.44. The Score for SMLP is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SMLP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
SMLP Stock Price Chart
What is Summit Midstream Partners LP's stock price today?
-
The Summit Midstream Partners LP share price today is $32.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMLP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.94 | Buy |
| Relative Strength Index (14 RSI): | 54.29 | Buy |
| Chaikin Money Flow: | 570345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.17 - 23.43) | Sell |
| Bollinger Bands (100): | (12.84 - 19.78) | Buy |
SMLP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 52.76 | Buy |
| Chaikin Money Flow: | 10169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.8 - 33.54) | Sell |
| Bollinger Bands (100): | (18.95 - 32.03) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.72 | Sell |
| 20-day SMA: | 22.35 | Sell |
| 50-day SMA: | 17.65 | Buy |
| 200-day SMA: | 15.52 | Buy |
| 8-day EMA: | 21.66 | Sell |
| 20-day EMA: | 21.27 | Buy |
| 50-day EMA: | 19.02 | Buy |
| 200-day EMA: | 21.91 | Sell |
SMLP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.06 | Buy |
| 20-day SMA: | 32.45 | Sell |
| 50-day SMA: | 31.07 | Buy |
| 200-day SMA: | 21.41 | Buy |
| 8-day EMA: | 32.05 | Buy |
| 20-day EMA: | 32.17 | Buy |
| 50-day EMA: | 30.44 | Buy |
| 200-day EMA: | 23.47 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.11 per share.
Summit Midstream Partners LP Earnings Growth & SMLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Midstream Partners LP Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||